KIM PETER S

USNatural personDirector

Insider

KIM PETER S

USNatural personDirector

Transactions

103

Issuers

Buys / Sells

11/1

Last tx

10 Jun 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Merck & Co., Inc.	189,608.9	reported	25 Feb 2013	tx 42+2,656,377.53−932,907
Entrada Therapeutics, Inc.	19,000	reported	10 Jun 2026	tx 21+201,122−11,918
MERCK & CO INC	0	reported	03 Nov 2009	tx 44+938,832−1,611,718.53

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.

1 month

−7.1%

Sample11

Win rate (≥5%)27%

Hit rate (>0)36%

3 months

+17.6%

Sample11

Win rate (≥5%)100%

Hit rate (>0)100%

6 months

+9.8%

Sample11

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
10 Jun 2026	GRANT_AWARD	Entrada Therapeutics, Inc.	19,000	0.00 USD	deriv
11 Jun 2025	GRANT_AWARD	Entrada Therapeutics, Inc.	19,000	0.00 USD	deriv
13 Jun 2024	GRANT_AWARD	Entrada Therapeutics, Inc.	16,000	0.00 USD	deriv
03 Jun 2024	EXERCISE

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Merck & Co., Inc.	189,608.9	reported	25 Feb 2013	tx 42+2,656,377.53−932,907
Entrada Therapeutics, Inc.	19,000	reported	10 Jun 2026	tx 21+201,122−11,918
MERCK & CO INC	0	reported	03 Nov 2009	tx 44+938,832−1,611,718.53

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.

1 month

−7.1%

Sample11

Win rate (≥5%)27%

Hit rate (>0)36%

3 months

+17.6%

Sample11

Win rate (≥5%)100%

Hit rate (>0)100%

6 months

+9.8%

Sample11